What is the address of MAFMED?

The registered office of MAFMED is located at Rue de la Flache 181, 7390 Quaregnon.

Is MAFMED still active?

Yes. According to the CBE (29 October 2026) MAFMED is active, legal situation “Normale toestand”, started on 24 December 2020.

Is MAFMED registered on Peppol?

Yes, MAFMED is registered on the Peppol network with ID 0208:0760557006.

What is the enterprise number of MAFMED?

The enterprise number of MAFMED is BE0760557006.

When was MAFMED founded?

MAFMED was founded on 24 December 2020.

Who are the directors of MAFMED?

According to the 2025 annual accounts, the directors of MAFMED are: Alessandro MAFFEO, Vanessa TAMAYO.

Is MAFMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 2020; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MAFMED make in 2025?

MAFMED posted a profit after taxes of € 187,282 in financial year 2025.

What is the revenue of MAFMED?

As a small company, MAFMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 245,024.

MAFMED (Private Limited) - Quaregnon - BE0760557006

Dossier MAFMED, printed on 29 October 2026 from databakkes.be/en/0760557006/mafmed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MAFMED from Quaregnon, company number BE0760557006, closed financial year 2025 with a result of € 187,282 after tax. For that financial year MAFMED recorded a gross margin of € 245,024 and equity of € 601,276. Compared with financial year 2024, the result moved from € 147,645 to € 187,282. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Growing

€ 601,276

▲ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 187,282

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1,150

▲ € 1,105 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 596,276.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 130,612

▼ 20% vs 2024

€ 41,130 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 6,954

▲ 45% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 71,647

▲ 2% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 201,118 Gross margin 2022: € 201,118 First fiscal year in the series	€ 179,661 Gross margin 2023: € 179,661 ▼ 11% vs 2022 (€ 201,118) Unfavourable step	€ 233,685 Gross margin 2024: € 233,685 ▲ 30% vs 2023 (€ 179,661) Favourable step	€ 245,024 Gross margin 2025: € 245,024 ▲ 5% vs 2024 (€ 233,685) Favourable step	▲ 5%
Profit after taxes	€ 132,882 Profit after taxes 2022: € 132,882 First fiscal year in the series	€ 109,508 Profit after taxes 2023: € 109,508 ▼ 18% vs 2022 (€ 132,882) Unfavourable step	€ 147,645 Profit after taxes 2024: € 147,645 ▲ 35% vs 2023 (€ 109,508) Favourable step	€ 187,282 Profit after taxes 2025: € 187,282 ▲ 27% vs 2024 (€ 147,645) Favourable step	▲ 27%
Equity	€ 156,841 Equity 2022: € 156,841 First fiscal year in the series	€ 266,349 Equity 2023: € 266,349 ▲ 70% vs 2022 (€ 156,841) Favourable step	€ 413,994 Equity 2024: € 413,994 ▲ 55% vs 2023 (€ 266,349) Favourable step	€ 601,276 Equity 2025: € 601,276 ▲ 45% vs 2024 (€ 413,994) Favourable step	▲ 45%
Total debts	€ 401,955 Total debts 2022: € 401,955 First fiscal year in the series	€ 290,628 Total debts 2023: € 290,628 ▼ 28% vs 2022 (€ 401,955) Favourable step	€ 303,006 Total debts 2024: € 303,006 ▲ 4% vs 2023 (€ 290,628) Unfavourable step	€ 232,253 Total debts 2025: € 232,253 ▼ 23% vs 2024 (€ 303,006) Favourable step	▼ 23%
Cash	€ 10,038 Cash 2022: € 10,038 First fiscal year in the series	€ 1,202 Cash 2023: € 1,202 ▼ 88% vs 2022 (€ 10,038) Unfavourable step	€ 45 Cash 2024: € 45 ▼ 96% vs 2023 (€ 1,202) Unfavourable step	€ 1,150 Cash 2025: € 1,150 ▲ € 1,105 vs 2024 (€ 45) Favourable step	▲ € 1,105
Retained profit	€ 151,841 Retained profit 2022: € 151,841 First fiscal year in the series	€ 261,349 Retained profit 2023: € 261,349 ▲ 72% vs 2022 (€ 151,841) Favourable step	€ 408,994 Retained profit 2024: € 408,994 ▲ 56% vs 2023 (€ 261,349) Favourable step	€ 596,276 Retained profit 2025: € 596,276 ▲ 46% vs 2024 (€ 408,994) Favourable step	▲ 46%
Dividend	€ 130,000 Dividend 2022: € 130,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 130,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 189,389 Bank debt 2022: € 189,389 First fiscal year in the series	€ 159,173 Bank debt 2023: € 159,173 ▼ 16% vs 2022 (€ 189,389) Favourable step	€ 163,733 Bank debt 2024: € 163,733 ▲ 3% vs 2023 (€ 159,173) Unfavourable step	€ 130,612 Bank debt 2025: € 130,612 ▼ 20% vs 2024 (€ 163,733) Favourable step	▼ 20%
Balance sheet total	€ 558,796 Balance sheet total 2022: € 558,796 First fiscal year in the series	€ 556,977 Balance sheet total 2023: € 556,977 Unchanged (€ 558,796) Unchanged	€ 717,000 Balance sheet total 2024: € 717,000 ▲ 29% vs 2023 (€ 556,977) Unchanged	€ 833,529 Balance sheet total 2025: € 833,529 ▲ 16% vs 2024 (€ 717,000) Unchanged	▲ 16%

Key figures of MAFMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MAFMED?

What happened at MAFMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 187,282 (▲ 27% vs 2024). Source: NBB ↗
Dec 24, 2020 Start of the company according to the CBE. KBO

In short

From € 132,882 profit in 2022 to € 187,282 profit in 2025.

Paid € 185,058 in corporate taxes since 2022.

Best year ever: 2025, with € 187,282 profit.

Paid out € 130,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Alessandro MAFFEO Vanessa TAMAYO

MAFFEO

CM Dourois

MAFMED

Behind MAFMED are Alessandro MAFFEO and Vanessa TAMAYO. The same people are also behind MAFFEO. Alessandro MAFFEO is also behind CM Dourois.

Directors

According to the 2025 annual accounts

Alessandro MAFFEO

Director

Also active at: MAFFEO, CM Dourois

Vanessa TAMAYO

Director

Also active at: MAFFEO

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Flache 181

7390 Quaregnon

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

MAFFEO same network

€ 6,426 gross margin · 2025

Fusion SLV

€ -19,541 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0760.557.006
VAT number: BE 0760.557.006
Registered office: Rue de la Flache 181, 7390 Quaregnon
Names & denominations: MAFMED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 December 2020
Peppol: Active · Active since 19 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗